Gelteq (NASDAQ:GELS) Issues Quarterly Earnings Results

Gelteq (NASDAQ:GELS – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.64) earnings per share for the quarter, FiscalAI reports.

Gelteq Price Performance

GELS stock traded down $0.06 during trading on Tuesday, hitting $0.30. 27,928 shares of the company’s stock traded hands, compared to its average volume of 2,154,683. Gelteq has a 52 week low of $0.31 and a 52 week high of $2.01. The business has a fifty day simple moving average of $0.52 and a 200 day simple moving average of $0.63.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Gelteq in a report on Tuesday, September 22nd. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Gelteq currently has an average rating of “Sell”.

Check Out Our Latest Stock Report on Gelteq

Gelteq Company Profile

(Get Free Report)

Gelteq is an Australian food-technology company that develops gel-based delivery systems for ingredients used in human and animal health products. Its platform is designed to incorporate active ingredients into gels as an alternative format to conventional tablets, capsules, powders and liquids. The company’s applications include nutraceuticals and dietary supplements, pharmaceutical products, and animal-health and nutrition products. Gelteq works with businesses seeking to develop or manufacture products using its gel technology.

Read More

Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.